16 results
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
1 Feb 21
Departure of Directors or Certain Officers
6:55am
Exhibit 99.1
Lead Independent Director Charter
If the Chairman of the Board of EyeGate Pharmaceutical, Inc. (the “Company”) is also an employee … director to serve in a lead capacity. Although elected annually, the Lead Independent Director is generally expected to serve for more than one year
8-K
KPRX
Kiora Pharmaceuticals Inc
1 Feb 21
Departure of Directors or Certain Officers
6:55am
in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
Appointment of Lead Independent Director
In connection … as non-executive Chairman, as Lead Independent Director, with the transition between those roles to occur as of the Effective Date. In connection
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
1 Feb 22
Kiora Pharmaceuticals Appoints Erin Parsons to its Board of Directors; Stephen From to Retire from Board
6:45am
accepted Stephen From’s voluntary resignation to pursue other activities. Paul Chaney, Kiora’s current Lead Independent Director, will be assuming
8-K
KPRX
Kiora Pharmaceuticals Inc
1 Feb 22
Kiora Pharmaceuticals Appoints Erin Parsons to its Board of Directors; Stephen From to Retire from Board
6:45am
, the Board appointed Paul Chaney as non-executive Chairman of the Board, and Mr. Chaney ceased serving as Lead Independent Director upon his appointment
8-K
EX-99.1
7t2wwtu iet1pyb
11 Jan 22
Regulation FD Disclosure
12:00am
- Prev
- 1
- Next